A new study of this pioneering new approach uses sound waves to heat and destroy tumors and leaves the healthy surrounding tissue untouched according to Science Daily. This minimally invasive method that is called MRI-guided transurethral ultrasound ablation (TULSA) relies on a rod-shaped device that is inserted directly into the urethra and are controlled by a software algorithm. What’s even more remarkable is that the entire procedure — called Tulsa-pro – is done in an MRI scanner and not in an operating room. This treatment is not available in North America at present. Read the article.
July 2017 Awareness Night Partial gland ablation for localized prostate cancer: Who is eligible and what are the risks? Dr. Nathan Perlis, MD, MSc, FRCSC Clinical assistant, Division of Urology, University Health Network Clinical fellow, Society of Urological Oncology, University of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 40:48 minutes
The challenge in prostate cancer (PCa) is to match the aggressiveness of the treatment to that of the cancer. Until recently, all screen-diagnosed localized cancers were considered at least potentially aggressive and in most cases were treated radically. Active surveillance represented a major step forward in acknowledging that some cancers were clinically insignificant and did not pose a threat to the patient’s life. Recently, a third option—focal therapy—has emerged as a potential middle ground between radical treatment and active surveillance. Read the article.
If you or someone close to you has lived with prostate cancer, you’ve probably come across dozens of emerging treatments in your hours of Googling. One such treatment, focal therapy, has been dubbed the “new pain-free treatment for prostate cancer”. But don’t hold your breath; it’s still in its experimental phases. This is a warning that focal therapy is still experimental and should be considered only in a clinical trial setting. Read the article.
Laser ablation, cryotherapy, and hemiablative brachytherapy are among the novel approaches that show promise for the focal treatment of localized prostate cancer (PCa), according to studies presented at the 28th annual congress of the European Association of Urology. Most of these treatments are performed under magnetic resonance imaging (MRI) guidance. Read the article.